Life ScienceCompany
Noven Pharmaceuticals M&A Summary
Noven Pharmaceuticals has acquired 2 companies. A total of 2 acquisitions came from private equity firms. It has also divested 1 asset.
Noven Pharmaceuticals’ largest acquisition to date was in 2007, when it acquired JDS Pharmaceuticals for $187M. It’s largest disclosed sale occurred in 2014, when it sold Noven Therapeutics - NDA Lithobid to ANI Pharmaceuticals for $12M. Noven Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Noven Pharmaceuticals Business Overview
Where is Noven Pharmaceuticals headquartered?
Noven Pharmaceuticals is headquartered in Miami, Florida.
How many employees does Noven Pharmaceuticals have?
Noven Pharmaceuticals has 650 employees.
What sector is Noven Pharmaceuticals in?
Noven Pharmaceuticals is a life science company.
When was Noven Pharmaceuticals founded?
Noven Pharmaceuticals was founded in 1987.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity1
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 3
- M&A Advisors 2